Diabetic Eye Problems
8
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye
Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
Diquafosol Ophthalmic Solution for Dry Eye Symptoms
Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye
Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy